ManageMR vs STEMIcathAID
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ManageMR
This medical app offers personalized referral and treatment guidance for mitral regurgitation patients. It analyzes echo assessment parameters to determine MR severity, etiology, and recommend appropriate interventions like valve repair or replacement.
- Personalized referral advice
- Treatment recommendations
- MR severity and etiology analysis
- Mitral valve repair vs. replacement feasibility
- Echo assessment parameter entry
Read full descriptionHide full description
This clinical decision support app provides clinicians with personalized referral and treatment advice for diagnosed mitral regurgitation patients by verifying the severity and etiology of the MR. • Enter patient parameters from an echo assessment. • Review customized advice on - Probable severity and etiology of a patient’s MR - Need for referral - Feasibility of mitral valve repair vs. replacement for the patient Content in this app is derived from the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation. The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
STEMIcathAID
This medical app streamlines STEMI treatment by optimizing patient recognition, response, and record-keeping. It enhances communication and coordination among healthcare providers, reducing critical time to reperfusion for high-risk patients. Features include EKG upload, cardiogenic shock assessment, and live GPS tracking.
- EKG upload via smartphone
- Cardiogenic shock assessment
- STEMI patient transfer pathway
- Live GPS tracking of EMS
- HIPAA compliant encrypted collaboration
- Notification system for cath lab preparation
Read full descriptionHide full description
STEMIcathAID is a patient recognition, response, and record-keeping system designed to improve outcomes through adherence the American Heart Association’s Mission:Lifeline STEMI guidelines. Early restoration of blood flow to occluded coronary vessels has been shown to significantly improve outcomes for high-risk STEMI patients. STEMIcathAID aims to improve these clinical outcomes by optimizing their treatment following many of the recommendations of the AHA by reducing the time to STEMI recognition, lead acquisition, STEMI identification, notification of the catheterization lab, and reperfusion. There are multiple personnel and steps involved in caring for these high-risk patients. STEMIcathAID takes an algorithmic approach which will enhance the coordination and communication tasks essential to rapid assessment and easy transfer of STEMI patients from the field or outside facility. It will also provide protocols for the EMS or outside hospital provider to identify patients in cardiogenic shock even before their arrival in the catheterization lab. The application will integrate live GPS tracking of the patients alongside the time the alarm was raised prompting the sense of urgency in transferring the patient. Incorporating images, videos, illustrations, and live GPS tracking of the EMS, the design will be subdivided into three main sections: 1. EKG Upload by outside facility or EMS 2. Assessment of Cardiogenic Shock 3. STEMI patient transfer pathway When a medical provider, in the field, other hospital, or outpatient office, suspects STEMI, the provider uploads the EKG by taking a picture of it with their phone. Once the EKG is uploaded, the on-call attending at the PCI-capable facility receives a notification from the application. If the attending believes the patient is experiencing a real STEMI, the pathway is activated. Upon activation, the approximately 10-12 people involved in taking care of the patient are notified so they can begin preparations. Adhering to HIPAA compliance, all users log into the encrypted application and begin to collaborate such aspects as patient vitals, shock information, and emergency vehicle current location and estimated arrival time to the cath lab. Through the optimized communication and collaboration of multiple key players in the STEMI pathway, these time-critical, vulnerable patients can begin treatment promptly.
Screenshots
Verdict
The clearest difference is rating: ManageMR at 5.0 against STEMIcathAID's 3.3. ManageMR also leads on iOS requirement (13.0 vs 15.1). STEMIcathAID's advantage is update cadence (every 3 months vs every 21 months) and ratings volume (8 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
ManageMR holds the better App Store score, 5.0 against 3.3. That said, the two scores are not equally well evidenced: STEMIcathAID has 8 ratings behind it against 1, so its average is the more settled of the two.
ManageMR ships an update every 21 months, STEMIcathAID every 3 months. Both last shipped on November 3, 2026.
| Parameter | ManageMR | STEMIcathAID |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | 3.3 (8 ratings) |
| Number of ratings | 1 | 8 — better |
| Update frequency | Every 21 months | Every 3 months — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 58 MB | 71 MB |
| Age rating | 17+ | 4+ |
| Developer | American College of Cardiology | Icahn School of Medicine at Mount Sinai |
Customer experience
ManageMR
STEMIcathAID
In-app purchases
ManageMR
No in-app purchases
STEMIcathAID
No in-app purchases








